UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment

Neuron (Cambridge, Mass.), 2019-03, Vol.101 (5), p.783-800

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England

The New England journal of medicine, 2021-08, Vol.385 (8), p.759-760

2021

Link zum Volltext

Verfügbarkeit prüfen

Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis

The Lancet infectious diseases, 2022-05, Vol.22 (5), p.603-610

2022

Link zum Volltext

Verfügbarkeit prüfen

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

The Lancet infectious diseases, 2014-09, Vol.14 (9), p.839-846

2014

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of maternal pertussis vaccination in England: an observational study

The Lancet (British edition), 2014-10, Vol.384 (9953), p.1521-1528

2014

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

The Lancet (British edition), 2016-12, Vol.388 (10061), p.2775-2782

2016

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study

Nature communications, 2022-09, Vol.13 (1), p.5736-5736, Article 5736

2022

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England

Nature medicine, 2022-04, Vol.28 (4), p.831-837

2022

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

The New England journal of medicine, 2021-08, Vol.385 (7), p.585-594

2021

Link zum Volltext

Verfügbarkeit prüfen

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

The Lancet (British edition), 2022-03, Vol.399 (10328), p.924-944

2022

Link zum Volltext

Verfügbarkeit prüfen

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

The New England journal of medicine, 2022-01, Vol.386 (4), p.340-350

2022

Link zum Volltext

Verfügbarkeit prüfen

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

Nature communications, 2021-12, Vol.12 (1), p.7217-7217, Article 7217

2021

Link zum Volltext

Verfügbarkeit prüfen

The Stage of the Estrus Cycle Is Critical for Interpretation of Female Mouse Social Interaction Behavior

Frontiers in behavioral neuroscience, 2020-06, Vol.14, p.113-113

2020

Link zum Volltext

Verfügbarkeit prüfen

Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction

Clinical infectious diseases, 2016-12, Vol.63 (suppl 4), p.S236-S243

2016

Link zum Volltext

Verfügbarkeit prüfen

Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study

PLoS medicine, 2019-07, Vol.16 (7), p.e1002845-e1002845

2019

Link zum Volltext

Verfügbarkeit prüfen

The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation

Vaccine, 2016-07, Vol.34 (32), p.3684-3689

2016

Link zum Volltext

Verfügbarkeit prüfen

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016

Emerging infectious diseases, 2017-07, Vol.23 (7), p.1184-1187

2017

Link zum Volltext

Verfügbarkeit prüfen

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

The Lancet (British edition), 2010-03, Vol.375 (9720), p.1100-1108

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales

Vaccine, 2012-11, Vol.30 (48), p.6802-6808

2012

Link zum Volltext

Verfügbarkeit prüfen

Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy

Frontiers in pharmacology, 2023-05, Vol.14, p.1173599-1173599

2023

Link zum Volltext

Verfügbarkeit prüfen

Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020

Euro surveillance : bulletin européen sur les maladies transmissibles, 2020-07, Vol.25 (26)

2020

Link zum Volltext

Verfügbarkeit prüfen

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial

The Lancet infectious diseases, 2018-02, Vol.18 (2), p.171-179

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016

Emerging infectious diseases, 2019-09, Vol.25 (9), p.1708-1718

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England

The Lancet regional health. Europe, 2022-02, Vol.13, p.100260-100260, Article 100260

2022

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014–2018

Clinical infectious diseases, 2020-11, Vol.71 (8), p.e235-e243

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.467

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.271)
Mit Volltextzugriff
(1.283)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(67)
Plos One
(46)
Clinical Infectious Diseases
(33)
Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles
(30)
Nature Communications
(29)
The New England Journal Of Medicine
(27)
Neurology
(24)
Nature
(22)
The Journal Of Infection
(22)
The Lancet
(21)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England

Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

Effectiveness of maternal pertussis vaccination in England: an observational study

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

The Stage of the Estrus Cycle Is Critical for Interpretation of Female Mouse Social Interaction Behavior

Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction

Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study

The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales

Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy

Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016

Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England

Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014–2018

Suchergebnisse filtern